Form 4 Filing for Michael F. Roman

Michael F. Roman, a director at ABBOTT LABORATORIES (ABT), reported a transaction on June 30, 2026. He acquired 416 Stock Equivalent Units, valued at $90.74 per unit, related to his director fees. These units are part of a deferred compensation plan where fees are credited to a stock equivalent unit account and paid in cash, generally at age 65 or upon retirement. The acquired units will earn returns as if invested in Abbott shares. Following this transaction, Roman holds 6746 Stock Equivalent Units. The acquisition was made under transaction code "A" for "Acquired". The filing also notes that the balance includes stock equivalent units acquired through a dividend reinvestment feature.